» Authors » Nobuhito Araki

Nobuhito Araki

Explore the profile of Nobuhito Araki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 2405
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawai A, Araki N, Ae K, Akiyama T, Ozaki T, Kawano H, et al.
J Orthop Sci . 2022 Mar; 27(3):533-550. PMID: 35339316
Background: These clinical practice guidelines are intended to provide recommendations based on the best evidence obtained to date on key issues in clinical practice to improve the prognosis, diagnostic and...
2.
Wakamatsu T, Imura Y, Tamiya H, Yagi T, Yasuda N, Nakai S, et al.
Cancers (Basel) . 2021 Sep; 13(18). PMID: 34572838
Retroperitoneal sarcomas are rare neoplasms that occur in the retroperitoneum. Complete surgical resection is the only effective treatment option. The prediction of prognosis by histological diagnosis has not yet been...
3.
Takenaka S, Araki N, Outani H, Hamada K, Yoshikawa H, Kamada T, et al.
Cancer . 2020 Jul; 126(18):4188-4196. PMID: 32658315
Background: To the authors' knowledge, carbon ion radiotherapy (CIRT) is one of the few curative treatments for unresectable pelvic bone sarcoma. The current study investigated the complications, functional outcomes, and...
4.
Takenaka S, Araki N, Ueda T, Kakunaga S, Imura Y, Hamada K, et al.
Sarcoma . 2020 Apr; 2020:9672093. PMID: 32317858
Methods: We retrospectively reviewed 33 patients who underwent osteoarticular ECIA after bone tumor resection from 1988 to 2014. We investigated complications, radiographic changes by the International Society of Limb Salvage...
5.
Outani H, Takenaka S, Hamada K, Imura Y, Kakunaga S, Tamiya H, et al.
J Surg Oncol . 2020 Apr; 121(8):1276-1282. PMID: 32246851
Background And Objectives: The aim of this study is to assess the survival, function, radiographic appearance, and modes of failure of extracorporeal irradiated (ECI) autografts in a long-term setting. Methods:...
6.
Mimura T, Yoshimura Y, Sano K, Araki N, Okamoto M, Kito M, et al.
J Orthop Sci . 2020 Apr; 27(6):1359-1362. PMID: 32229164
No abstract available.
7.
Endo M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, et al.
Cancer Med . 2020 Mar; 9(11):3656-3667. PMID: 32220056
The time course of the response to each drug is important to avoid inappropriate termination of treatment by misjudging tumor progression; however, little is known about soft tissue sarcoma (STS)...
8.
Outani H, Kakunaga S, Hamada K, Takenaka S, Nakai S, Yasuda N, et al.
World J Surg Oncol . 2020 Mar; 18(1):47. PMID: 32122388
Background: Chondroblastoma (CB) is a rare locally aggressive bone tumor that commonly occurs in the epiphysis or apophysis of long bones. Although surgical treatment of CB carries potential risk for...
9.
Nakai S, Yamada S, Outani H, Nakai T, Yasuda N, Mae H, et al.
Sci Rep . 2020 Jan; 10(1):684. PMID: 31941891
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
10.
Nakai S, Tamiya H, Imura Y, Nakai T, Yasuda N, Wakamatsu T, et al.
Mol Cancer Ther . 2019 Dec; 19(3):742-754. PMID: 31796507
Clear cell sarcoma (CCS) is a rare but chemotherapy-resistant and often fatal high-grade soft-tissue sarcoma (STS) characterized by melanocytic differentiation under control of microphthalmia-associated transcription factor (MITF). Eribulin mesilate (eribulin)...